- Tainted Cucumbers Now Linked to 100 Salmonella Cases in 23 States
- Check Your Pantry, Lay’s Classic Potato Chips Recalled Due to Milk Allergy Risk
- Norovirus Sickens Hundreds on Three Cruise Ships: CDC
- Not Just Blabber: What Baby’s First Vocalizations and Coos Can Tell Us
- What’s the Link Between Memory Problems and Sexism?
- Supreme Court to Decide on South Carolina’s Bid to Cut Funding for Planned Parenthood
- Antibiotics Do Not Increase Risks for Cognitive Decline, Dementia in Older Adults, New Data Says
- A New Way to Treat Sjögren’s Disease? Researchers Are Hopeful
- Some Abortion Pill Users Surprised By Pain, Study Says
- Who is At Risk For Cybercrime?
-
Mosquitoes Test Positive for Malaria in Florida
Public health authorities are continuing to investigate malaria cases in Florida and Texas, gathering mosquitoes for tests. Multiple mosquitoes from Sarasota County in Florida have tested positive for malaria at a U.S. Centers for Disease Control and...
- Posted June 30, 2023
-
WHO Experts Take Another Look at Aspartame’s Safety
The artificial sweetener aspartame is in the hot seat once more. Two separate committees made up of health experts from around the world will soon offer advice on consuming aspartame, a popular sugar substitute that is added...
- Posted June 30, 2023
-
AHA News: Are You Getting Enough Omega-3 Fatty Acids?
FRIDAY, June 30, 2023 (American Heart Association News) — Omega-3 fatty acids play an important role in heart and brain health. They’ve been linked to a stronger immune system, reduced inflammation and lower blood pressure and triglycerides,...
- Posted June 30, 2023
-
Soaring Misuse of Horse Tranquilizer Xylazine Is Worsening Opioid Crisis
Drug overdose deaths involving a powerful horse tranquilizer called xylazine have skyrocketed in the United States, rising 35-fold in just a handful of years, federal health researchers say. The number of xylazine-involved OD deaths nationwide rose from...
- Posted June 30, 2023
-
FDA Approves First Gene Therapy for Severe Hemophilia A
The U.S. Food and Drug Administration on Thursday approved a costly single-dose gene therapy for patients with severe hemophilia A, a life-threatening hereditary bleeding disorder. The treatment is not cheap: Roctavian will cost $2.9 million for a...
- Posted June 30, 2023
-
Science Brings New Insight Into Origins of OCD
California psychiatrist Dr. Carolyn Rodriguez once had a patient with obsessive-compulsive disorder (OCD) who washed his hands so often that he had to wear gloves to cover his cracked and swollen skin. “People with intrusive thoughts of...
- Posted June 30, 2023
-
Fixing a Painful Joint Problem Won’t Ease Mental Health Ills, Study Finds
Blaming your ailing knees for feeling down? Unfortunately, even after physical pain eases, healing or fixing an injured joint often does not improve mental health, research shows. A new study found that anxiety symptoms only improved when...
- Posted June 30, 2023
-
Heat Waves a Hazard for People With Dementia
(HealthDay News) – Heat waves that hit the triple digits, like the ones now gripping many parts of the United States this week, can create dangerous conditions for folks who are vulnerable. One vulnerable group is people...
- Posted June 30, 2023
-
Air Polluted With Wildfire Smoke Can Harm Animals, Too
The Canadian wildfires that are burning out of control have brought hazy skies and polluted air to parts of the United States unprepared for it — and that’s affecting not just the people, but their pets and...
- Posted June 30, 2023
-
Scientists Use Stem Cells to Replicate Early Human Embryo
(HealthDay News) – Scientists hope to learn more about the earliest stages of human development using models of embryos created from stem cells. The models, from University of Cambridge scientists, could ultimately shed light on why and...
- Posted June 30, 2023